Waters CORP /DE/ DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Waters Corporation's 2026 proxy statement details strong 2025 financial performance, the acquisition of BD's Biosciences & Diagnostic Solutions, and governance updates.
NYSE
Waters Corporation will hold its annual shareholder meeting virtually on May 22, 2025, to vote on director elections, auditor ratification, executive compensation, and an employee stock purchase plan.
NYSE
Waters Corporation is entering a new era of growth, focusing on operational excellence, new product launches, and expanding into adjacent markets, while maintaining strong corporate governance and shareholder returns.
NYSE
Waters Corporation will hold its annual shareholder meeting on May 23, 2024, to elect directors, ratify the selection of PricewaterhouseCoopers LLP, approve executive compensation, and amend the company's certificate of incorporation.
NYSE
Waters Corporation's proxy statement outlines proposals for shareholder voting, including officer exculpation and executive compensation, while reviewing the company's performance and governance.